CytoMed Therapeutics annual revenue
2024
2025
CytoMed Therapeutics Revenue Growth & History (GDTC)
CytoMed Therapeutics reported $324,387 in revenue for fiscal 2025, an increase of 366.74% from the previous fiscal year.
View full CytoMed Therapeutics company overviewCytoMed Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $324,387 | $254,886 | +366.74% |
| 2024 | 2024-12-31 | $69,501 | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review CytoMed Therapeutics filings at SEC.gov ↗